| RAD140 |
RAD-140 |
1182367-47-0 |
| BMS-794833 |
BMS-794833 |
1174046-72-0 |
| LGD-4033 |
LGD4033 |
1165910-22-4 |
| A66 |
A66 |
1166227-08-2 |
| Tildacerfont |
Tildacerfont |
1014983-00-6 |
| IMMunoglobulin G2 |
吉伏组单抗 |
1129435-60-4 |
| IM-12 |
IM-12 |
1129669-05-1 |
| LDN-193189 |
LDN-193189 |
1062368-24-4 |
| RO3280 |
RO3280 |
1062243-51-9 |
| Tipifarnib |
替吡法尼 |
192185-72-1 |
| CRT5 |
CRT5 |
1034297-58-9 |
| 3-(2-chloropyriMidin-4-yl)-1-Methylindole |
3-(2-氯嘧啶-4-基)-1-甲基吲哚 |
1032452-86-0 |
| CC-122 |
3-(5-氨基-2-甲基-4-氧代喹唑啉-3(4H)-基)哌啶-2,6-二酮 |
1015474-32-4 |
| 6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one |
6-溴-2-氯-8-环戊基-5-甲基-吡啶并[2,3-D]嘧啶-7(8H)-酮 |
1016636-76-2 |
| clenoliximab |
clenoliximab |
182912-58-9 |
| Oseltamivir |
奥司他韦 |
196618-13-0 |
| AP20187 |
AP 20187 |
195514-80-8 |
| Rituximab |
利妥昔单抗 |
174722-31-7 |
| Keliximab |
凯利昔单抗 |
174722-30-6 |
| N-[(1R)-1-[[[[4-[[(Aminocarbonyl)amino]methyl]phenyl]methyl]amino]carbonyl]-4-[(aminoiminomethyl)amino]butyl]-α-phenyl-benzeneacetamideditrifluoroacetate |
N-[(1R)-1-[[[[4-[[(Aminocarbonyl)amino]methyl]phenyl]methyl]amino]carbonyl]-4-[(aminoiminomethyl)amino]butyl]-α-phenyl-benzeneacetamideditrifluoroacetate |
191868-14-1 |
QQ
微信
